Invezz

Z Squared (ZSQR)

Nasdaq Market Open

Z Squared Inc. is a publicly traded digital asset mining company focused on operating cryptocurrency mining infrastructure across multiple locations in North America. The company describes itself as vertically integrated, meaning it seeks to control key parts of the mining process, from site operations and equipment deployment to asset-specific mining strategies.

Its mining footprint includes facilities in Texas, North Carolina, South Carolina, and Iowa. This geographic spread gives the company exposure to different power markets, operating conditions, and infrastructure environments, which are important considerations for mining businesses where electricity cost, equipment uptime, and cooling efficiency can have a material effect on profitability.

Z Squared mines a diversified set of cryptocurrencies rather than limiting its operations to a single network. Its portfolio includes assets such as Dogecoin and Litecoin, both of which use proof-of-work mining models linked to Scrypt-based hardware. The company also references strategies across algorithms including SHA-256, Scrypt, and kHeavyHash, indicating an emphasis on matching mining equipment and operating plans to the economics of individual digital assets.

The company’s hardware fleet includes specialised ASIC miners, including Antminer models such as the L7, L9, and DG1+. ASIC-based mining is capital intensive and highly competitive, requiring ongoing attention to hash rate, network difficulty, energy pricing, and equipment efficiency. As a listed stock with direct exposure to cryptocurrency mining, Z Squared gives investors a way to follow the economics of proof-of-work digital assets through an operating company rather than through direct ownership of tokens.

9.75 USD
−0.45 (-4.04%)

Last updated

Market Cap
102.06M
P/E
P/FCF
P/S
72.18
Enterprise Value
97M
Sector
Industry
Address
105 BRADFORD ROAD, SUITE 420, WEXFORD, PA, 15090

No recent news is linked to this listing.

Market Cap
102.06M
Enterprise Value
97M
P/E
P/B
5.94
P/S
72.18
EV / EBITDA
-8.28
EV / Sales
68.6
EPS
-1.99
Dividend Yield
0%
P/FCF
P/CF
Free Cash Flow
ROE
-72.26%
ROA
-62.73%
Debt / Equity
0.01
Current Ratio
3.25
Quick Ratio
3.25
Cash
2.87
Avg Volume
54.18K
Fundamentals Snapshot Price
16.4

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 113.77K 862.05K 237.44K 200.68K 62.87K
Gross profit 68.62K 816.89K 192.29K 155.52K 17.72K
Operating income -3.91M -1.99M -2.48M -4.52M -4.06M
EBITDA -3.62M -1.69M -2.18M -4.23M -3.76M
Net income -3.92M -1.26M -2.9M -4.33M -3.36M
Basic EPS -0.65 -0.04 -0.61 -1.17 -1.1
Diluted EPS -0.65 -0.04 -0.61 -1.17 -1.1

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 19.79M 16.15M 14.18M 12.19M 13.45M
Total liabilities 2.21M 2.09M 3.26M 5.11M 5.99M
Total equity 17.58M 14.07M 10.92M 7.08M 7.46M
Cash & equivalents 5.21M 5.67M 4.91M 2M 4.27M
Current assets 5.91M 7.35M 5.99M 3.69M 4.65M
Current liabilities 1.82M 1.77M 2.71M 4.48M 5.65M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow -1.76M -1.69M -2.15M -2.4M -2.37M
Investing cash flow 591.52K
Financing cash flow 704.25K 2.45M 5.06M 125.1K 6.1M
Change in cash -463.11K 765.82K 2.91M -2.27M 3.74M
Kind Filing Date Link
edgar index 8-K/A — Z Squared Inc. View Filing
edgar index 8-K — Z Squared Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — Z Squared Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 10-Q — Z Squared Inc. View Filing
edgar index SCHEDULE 13D/A — Z Squared Inc. View Filing
edgar index 4 — Z Squared Inc. View Filing
edgar index 3 — Z Squared Inc. View Filing
edgar index SCHEDULE 13D — Z Squared Inc. View Filing
edgar index SCHEDULE 13G — Z Squared Inc. View Filing
form 3 Form 3 — BSG Series CM, LLC View Filing
edgar index 8-K — Z Squared Inc. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — BSG Series CM, LLC View Filing
edgar index 3 — Z Squared Inc. View Filing
edgar index 3 — Z Squared Inc. View Filing
edgar index 3 — Z Squared Inc. View Filing
edgar index 3 — Z Squared Inc. View Filing
edgar index 3 — Z Squared Inc. View Filing
edgar index 3 — Z Squared Inc. View Filing
form 3 Form 3 — Halabu David Elias View Filing
edgar index 8-K — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index SCHEDULE 13G — Coeptis Therapeutics Holdings, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 25-NSE — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 8-K — Coeptis Therapeutics Holdings, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 424B3 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 144 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 8-K — Coeptis Therapeutics Holdings, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G/A — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 424B3 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 424B3 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 424B3 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 10-K — Coeptis Therapeutics Holdings, Inc. View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing
ten k section 10-K — risk_factors View Filing
edgar index 4 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 4 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 4 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 4 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 4 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 4 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 4 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 4 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 4 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 8-K — Coeptis Therapeutics Holdings, Inc. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Sheehy Christine Elise View Filing
form 4 Form 4 — Sheehy Christine Elise View Filing
form 4 Form 4 — Salkind Gene View Filing
form 4 Form 4 — Salkind Gene View Filing
form 4 Form 4 — Cochran Christopher P. View Filing
form 4 Form 4 — Cochran Christopher P. View Filing
form 4 Form 4 — DeSilva Tara View Filing
form 4 Form 4 — DeSilva Tara View Filing
form 4 Form 4 — Yerace Daniel Alexander View Filing
form 4 Form 4 — Yerace Daniel Alexander View Filing
form 4 Form 4 — Mehalick David View Filing
form 4 Form 4 — Mehalick David View Filing
form 4 Form 4 — Calise Chris View Filing
form 4 Form 4 — Calise Chris View Filing
form 4 Form 4 — Deschamps Philippe View Filing
form 4 Form 4 — Deschamps Philippe View Filing
form 4 Form 4 — Cogley Brian View Filing
form 4 Form 4 — Cogley Brian View Filing
edgar index 8-K — Coeptis Therapeutics Holdings, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index DEFA14A — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 424B3 — Coeptis Therapeutics Holdings, Inc. View Filing
edgar index 8-K — Coeptis Therapeutics Holdings, Inc. View Filing